ZMUni Compliance Centre

    On April 30, 2026, China's State Administration for Market Regulation (SAMR) and the Standardization Administration of China (SAC) jointly issued GB 26396-2026 Safety Technical Specification for Cleaning Products (the "Standard”), replacing the previous recommended standard GB/T 26396-2011 Technical Specification for Safety of Soaps and Detergents.   The new Standard upgrades cleaning product safety requirements from a recommended national standard to a mandatory national standard and will take effect on May 1, 2027. From this date, cleaning products placed on the Chinese market must comply with the new requirements on ingredients, labeling, and safety documentation.   This article highlights

    The Cosmetic Product Information File (PIF) system in Taiwan was introduced in 2019 and gradually implemented through a three-phase rollout. As of July 1, 2026, the PIF requirements have become fully effective for all cosmetic products placed on the Taiwan market.   Under the new requirements, brand owners, manufacturers, and importers must prepare and maintain complete PIF documentation before placing cosmetic products on the market. ZMUni Compliance Centre summarizes the key requirements and frequently asked questions to help businesses better understand their compliance obligations.     What is a Product Information File (PIF)?   A Product Information File

   From July 1 to 7, a total of five new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not been publicly disclosed.      S-{8-[(4,4,4-trifluorobutyl)sulfanyl]octyl}(2,3-dihydroxyphenyl)methanethioate (Notification No.2026018)   S-{8-[(4,4,4-trifluorobutyl)sulfanyl]octyl}(2,3-dihydroxyphenyl)methanethioate is a chemically synthesized cosmetic ingredient. Based on efficacy tests and in vitro studies, it can help improve TEWL, skin softness, and hair shine, and may be used as a skin protectant, emollient, and hair conditioning agent.   With regulatory support from ZMUni Compliance Centre, this ingredient completed its NCI notification and entered the public disclosure stage, marking the

    During the last week of June 2026, a total of six new cosmetic ingredients completed notification with China's National Medical Products Administration (NMPA). The technical requirements for all related NCIs have not been publicly disclosed.     Ginsenoside Compound K (Notification No.20260111)   According to the notifier Giant Biogene, this Ginsenoside Compound K adopts a differentiated production pathway, integrating an enzyme-directed biotransformation process with high-purity preparative separation technology for rare ginsenosides.   The notified ingredient is positioned for skin barrier repair and sebum regulation, addressing key concerns in oily and acne-prone skin.     Photoinitiators (Notification No.20260113 and

From June 15 to June 23, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA). The technical requirements have not been disclosed yet.     Polymers   Notification No. 20260104  Hydrogenated Soy Polyglycerides is the product obtained through catalytic metathesis of Glycine Soja (Soybean) Oil, followed by hydrogenation. According to PCPC, its functions include Skin-Conditioning Agent (Occlusive) and Viscosity Increasing Agent (Nonaqueous). This notification marks the first NCI submission from a Singapore-based company under China's NCI framework.   Notification No. 20260105 and Notification No. 20260106 In this issue, Intercos S.p.A. notified two NCIs, both

"Plant-derived exosomes" have become a focal point in global cosmetic ingredient innovation due to their natural origin, biocompatibility, and targeted delivery capabilities. However, as an emerging bio-based ingredient, they still face significant regulatory hurdles in China—including scientific nomenclature, classification as "New Cosmetic Ingredients" (NCI), and the design of appropriate notification and registration pathways.   This article provides a structured overview of how these materials are currently understood under China’s regulatory framework, with reference to international nomenclature practices and key compliance considerations.     01. Nomenclature: The "Vesicle" vs. "Exosome" Distinction   Under the International Nomenclature of Cosmetic Ingredients (INCI) framework,

  From June 8 to June 12, 2026, 7 new cosmetic ingredients (NCIs) have completed notifications with China's National Medical Products Administration (NMPA).     Peptides   Notification No. 20260097 - sr-(Tripeptide-133 sh-Polypeptide-2 Hexapeptide-40)   According to the publicly available patent filed by the notifier (CN120918980A), sr-(Tripeptide-133 sh-Polypeptide-2 Hexapeptide-40) demonstrates strong antioxidant activity and can act synergistically with other active ingredients. It enables the development of a new, high-performance active ingredient system applicable in both skincare and hair care products, enhancing antioxidant and repair-related efficacy.     Notification No. 20260100   Hexapeptide-125 (translated from Chinese name, official INCI name currently

  From May 26 to June 3, 2026, 6 new cosmetic ingredients (NCIs) have completed notifications with China’s National Medical Products Administration (NMPA).     Rosa Alba Flower Water   Rosa alba (White Rose) is a classic botanical prized for centuries in both Eastern and Western cultures. Renowned for its delicate fragrance and pure white blossoms, it has traditionally been used in soothing skincare and aromatic applications, combining natural beauty with botanical care.     Pyropia Haitanensis Extract   Pyropia haitanensis is an edible red algae mainly found along the southeastern coast of China, particularly in Zhejiang and Fujian provinces.